Towa Pharmaceutical Co., Ltd.

TSE:4553 Stok Raporu

Piyasa değeri: JP¥151.8b

Towa Pharmaceutical Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Towa Pharmaceutical's earnings have been declining at an average annual rate of -8.2%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 16.6% per year. Towa Pharmaceutical's return on equity is 10.4%, and it has net margins of 7.2%.

Anahtar bilgiler

-8.2%

Kazanç büyüme oranı

-8.2%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi3.4%
Gelir büyüme oranı16.6%
Özkaynak getirisi10.4%
Net Marj7.2%
Sonraki Kazanç Güncellemesi12 Nov 2024

Yakın geçmiş performans güncellemeleri

Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Jul 03
Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Recent updates

Towa Pharmaceutical (TSE:4553) Will Pay A Dividend Of ¥30.00

Sep 05
Towa Pharmaceutical (TSE:4553) Will Pay A Dividend Of ¥30.00

Towa Pharmaceutical (TSE:4553) Is Due To Pay A Dividend Of ¥30.00

Aug 15
Towa Pharmaceutical (TSE:4553) Is Due To Pay A Dividend Of ¥30.00

Fewer Investors Than Expected Jumping On Towa Pharmaceutical Co., Ltd. (TSE:4553)

Aug 03
Fewer Investors Than Expected Jumping On Towa Pharmaceutical Co., Ltd. (TSE:4553)

Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Jul 03
Towa Pharmaceutical's (TSE:4553) Earnings Are Weaker Than They Seem

Gelir ve Gider Dağılımı

Towa Pharmaceutical nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:4553 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24235,95216,91865,4930
31 Mar 24227,93416,17350,49313,242
31 Dec 23236,77911,73553,43815,265
30 Sep 23225,7556,46253,21715,265
30 Jun 23218,0355,55653,12015,265
31 Mar 23208,8592,20151,93415,265
31 Dec 22180,4072,89849,08711,488
30 Sep 22173,8619,36445,04811,488
30 Jun 22168,06011,99842,72011,488
31 Mar 22165,61515,91440,16011,488
31 Dec 21165,26219,51138,35310,642
30 Sep 21162,51416,94937,40310,642
30 Jun 21159,92715,93435,72210,642
31 Mar 21154,90013,95834,88110,642
31 Dec 20141,23012,98134,2538,566
30 Sep 20129,67413,68831,5468,566
30 Jun 20119,87814,07429,1378,566
31 Mar 20110,38414,50325,9098,566
31 Dec 19111,21813,98925,4757,916
30 Sep 19111,31514,36425,2967,916
30 Jun 19108,01613,67324,1987,916
31 Mar 19105,10413,47524,2007,916
31 Dec 18101,3099,57723,7327,725
30 Sep 1897,8718,36923,6527,725
30 Jun 1896,4118,05624,1947,725
31 Mar 1893,4306,49523,6827,725
31 Dec 1791,6608,14522,4729,352
30 Sep 1789,1269,79422,3019,352
30 Jun 1787,2858,68022,4819,352
31 Mar 1784,9495,57622,5529,352
31 Dec 1684,5826,18023,4118,924
30 Sep 1683,4743,75523,5008,924
30 Jun 1682,8624,34522,6578,924
31 Mar 1682,1157,68421,7958,924
31 Dec 1579,6498,52123,2596,144
30 Sep 1577,16411,06422,0086,144
30 Jun 1574,41412,07620,4646,144
31 Mar 1571,47011,11819,7236,144
31 Dec 1469,1819,75819,2585,296
30 Sep 1466,2608,04118,3735,296
30 Jun 1463,2326,07518,1265,296
31 Mar 1461,3515,99217,1445,296
31 Dec 1358,7626,34217,1634,478

Kaliteli Kazançlar: 4553 has high quality earnings.

Büyüyen Kar Marjı: 4553's current net profit margins (7.2%) are higher than last year (2.5%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 4553's earnings have declined by 8.2% per year over the past 5 years.

Büyüme Hızlandırma: 4553's earnings growth over the past year (204.5%) exceeds its 5-year average (-8.2% per year).

Kazançlar vs. Sektör: 4553 earnings growth over the past year (204.5%) exceeded the Pharmaceuticals industry 38.7%.

Özkaynak Getirisi

Yüksek ROE: 4553's Return on Equity (10.4%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y